| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |